Skip to main content

Table 3 Patient characteristics

From: The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma

Patient data

Number of patients

36

Age (years)

55 (43–67)

Female

14 (39%)

Calcitonin level (pg/mL)

1377 (279–2850)

CEA level (pg/mL)

19 (5–125)

Liver metastases

16 (44%)

Lymph node metastases

31 (86%)

Pulmonary metastases

11 (31%)

Bone metastases

7 (19%)

Soft tissue metastases

1 (3%)

Hereditary MTC

5 (14%)

  1. Values presented are count (percentage) for categorical and median (interquartile range) for ordinal or continuous variables
  2. CEA carcinoembryonic antigen, MTC medullary thyroid carcinoma